Guest Contributor

Basic research increases share of medical R&D according to latest PMPRB report

Guest Contributor
July 7, 2003

Spending by the patented pharmaceutical industry on basic research reached $198.6 million in 2002, accounting for 17.6% of all R&D outlays. The 21.8% increase over 2001 reverses a seven-year decline in the proportion of R&D expenditures devoted to basic research, according to the fifteenth annual report by the Patented Medicine Prices Review Board (PMPRB).

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

DFAIT S&T Division makes progress learning how to do more with existing resources

Corporate R&D spending posts modest increase as companies hang tough

Growth in biotechnology sector slowed in 2000 before impact of high-tech downturn

Blueprint initiative receives $29 million in funding






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.